Evidence map›Paper›PMID 41472293›Full record

ArticleViruses2025

Study of the Activity of the

Nino Grdzelishvili, Davit Lazviashvili, Aleksandra Kurowska, Krzysztof Jakub Pawlik, Łukasz Łaczmanski, Elene Kakabadze, Elene Zhuravliova, Nina Chanishvili, Nata Bakuradze

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nino GrdzelishviliLaboratory of Microbial Biotechnology, George Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi 0160, Georgia.
Davit LazviashviliLaboratory of Microbial Biotechnology, George Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi 0160, Georgia.ORCID 0009-0004-7402-6892
Aleksandra KurowskaSchool of Natural Sciences and Medicine, Ilia State University, Tbilisi 0179, Georgia.ORCID 0000-0001-5950-0358
Krzysztof Jakub PawlikHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.ORCID 0000-0002-5881-9292
Łukasz ŁaczmanskiHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.ORCID 0000-0002-0874-5483
Elene KakabadzeLaboratory of Microbial Biotechnology, George Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi 0160, Georgia.
Elene ZhuravliovaSchool of Natural Sciences and Medicine, Ilia State University, Tbilisi 0179, Georgia.
Nina ChanishviliLaboratory of Microbial Biotechnology, George Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi 0160, Georgia.ORCID 0000-0002-7859-3032
Nata BakuradzeLaboratory of Microbial Biotechnology, George Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi 0160, Georgia.ORCID 0000-0003-4218-383X

Funding

Eliava Foundation- Association for Bacteriophage development in Georgia #3010Horizon 2020 767015
6 · The paper itself

Abstract

Bacteriophage therapy is regarded as a promising alternative for treating and preventing antibiotic-resistant bacterial infections. Methicillin-resistant

Indexed as

BiofilmsMethicillin-Resistant Staphylococcus aureusPseudomonas aeruginosaStaphylococcus PhagesGenome, ViralHost SpecificityHumansPhage TherapyStaphylococcal InfectionsWhole Genome Sequencinganti-biofilm activitybacteriophageMRSAP. aeruginosa

Identifiers

PMID41472293
PMCPMC12737361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.